UB Paderborn / Katalog / Suche / in CDI

Ledipasvir and sofosbuvir plus ribavirin in patients with genotype 1 or 4 hepatitis C virus infection and advanced liver disease: a multicentre, open-label, randomised, phase 2 trial

The Lancet infectious diseases, 2016-06, Vol.16 (6), p.685-697

2016

Volltextzugriff (PDF)

Sofosbuvir and Ribavirin for Treatment of Compensated Recurrent Hepatitis C Virus Infection After Liver Transplantation

Gastroenterology (New York, N.Y. 1943), 2015, Vol.148 (1), p.108-117

2015

Volltextzugriff (PDF)

Sofosbuvir and Ribavirin Prevent Recurrence of HCV Infection After Liver Transplantation: An Open-Label Study

Gastroenterology (New York, N.Y. 1943), 2015, Vol.148 (1), p.100-107.e1

2015

Volltextzugriff (PDF)

Pharmacokinetics, Pharmacodynamics, and Tolerability of GS-9851, a Nucleotide Analog Polymerase Inhibitor, following Multiple Ascending Doses in Patients with Chronic Hepatitis C Infection

Antimicrobial Agents and Chemotherapy, 2013-03, Vol.57 (3), p.1209-1217

2013

Volltextzugriff (PDF)

Pharmacokinetics, Safety, and Tolerability of GS-9851, a Nucleotide Analog Polymerase Inhibitor for Hepatitis C Virus, following Single Ascending Doses in Healthy Subjects

Antimicrobial Agents and Chemotherapy, 2013-03, Vol.57 (3), p.1201-1208

2013

Volltextzugriff (PDF)

A trial design to maximize knowledge of the effects of rodatristat ethyl in the treatment of pulmonary arterial hypertension (ELEVATE 2)

Pulmonary circulation, 2022-04, Vol.12 (2), p.e12088-n/a

2022

Volltextzugriff (PDF)

Ledipasvir and Sofosbuvir Plus Ribavirin for Treatment of HCV Infection in Patients With Advanced Liver Disease

Gastroenterology (New York, N.Y. 1943), 2015-09, Vol.149 (3), p.649-659

2015

Volltextzugriff (PDF)

Sofosbuvir compassionate use program for patients with severe recurrent hepatitis C after liver transplantation

Hepatology (Baltimore, Md.), 2015-05, Vol.61 (5), p.1485-1494

2015

Volltextzugriff (PDF)

Pair Programming in Middle School: What Does It Look Like?

Journal of research on technology in education, 2009-01, Vol.42 (1), p.29-49

2009

Volltextzugriff (PDF)

Safety and efficacy of rodatristat ethyl for the treatment of pulmonary arterial hypertension (ELEVATE-2): a dose-ranging, randomised, multicentre, phase 2b trial

The lancet respiratory medicine, 2024-11, Vol.12 (11), p.865-876

2024

Volltextzugriff (PDF)

Analysis of hepatitis C viral kinetics during administration of two nucleotide analogues: sofosbuvir (GS―7977) and GS―0938

Antiviral therapy, 2014-01, Vol.19 (2), p.211-220

2014

Volltextzugriff (PDF)

Hepatitis C Virus RNA Persists in Liver Explants of Most Patients Awaiting Liver Transplantation Treated With an Interferon-Free Regimen

Gastroenterology (New York, N.Y. 1943), 2016-10, Vol.151 (4), p.633-636.e3

2016

Volltextzugriff (PDF)

365 Ledipasvir/Sofosbuvir With Ribavirin Is Safe and Efficacious in Decompensated and Post Liver Transplantation Patients With HCV Infection: Preliminary Results of the Prospective SOLAR 2 Trial

Gastroenterology (New York, N.Y. 1943), 2015-04, Vol.148 (4), p.S-978-S-978

2015

Volltextzugriff (PDF)

Tu1021 Ledipasvir/Sofosbuvir With Ribavirin for the Treatment of Fibrosing Cholestatic Hepatitis C After Liver Transplantation

Gastroenterology (New York, N.Y. 1943), 2015-04, Vol.148 (4), p.S-1086-S-1087

2015

Volltextzugriff (PDF)

226 Ledipasvir/Sofosbuvir With Ribavirin Is Safe in >600 Decompensated and Post Liver Transplantation Patients With HCV Infection: An Integrated Safety Analysis of the Solar 1 and Solar 2 Trials

Gastroenterology (New York, N.Y. 1943), 2015-04, Vol.148 (4), p.S-971-S-971

2015

Volltextzugriff (PDF)

On-treatment HCV RNA in patients with varying degrees of fibrosis and cirrhosis in the SOLAR-1 trial

Antiviral therapy, 2016-01, Vol.21 (6), p.541-546

2016

Volltextzugriff (PDF)

SAFETY AND PHARMACOKINETICS OF GR270773, A NOVEL ANTISEPSIS COMPOUND, IN SEPTIC PATIENTS: 618

Critical care medicine, 2004-12, Vol.32 (Supplement), p.A174

2004

Volltextzugriff (PDF)

Adult bone marrow is a rich source of human mesenchymal ‘stem’ cells but umbilical cord and mobilized adult blood are not

British journal of haematology, 2003-04, Vol.121 (2), p.368-374

2003

Volltextzugriff (PDF)

Reducing Wet Ammonium Deposition in Rocky Mountain National Park: the Development and Evaluation of A Pilot Early Warning System for Agricultural Operations in Eastern Colorado

Environmental management (New York), 2019-11, Vol.64 (5), p.626-639

2019

Volltextzugriff (PDF)

Variations in the Management of Closed Salter-Harris II Distal Tibia Fractures

Journal of pediatric orthopaedics, 2023-10, Vol.43 (9), p.e742-e746

2023

Volltextzugriff (PDF)

Age and CRP Associated With Improved Tissue Pathogen Identification in Children With Blood Culture Negative Osteomyelitis: Results From the CORTICES Multicenter Database

Journal of pediatric orthopaedics, 2023-09, Vol.43 (8), p.e603-e607

2023

Volltextzugriff (PDF)

Endothelial cell precursors are normal components of human umbilical cord blood

British journal of haematology, 1997-09, Vol.98 (3), p.775-777

1997

Volltextzugriff (PDF)

Cytokine Expansion Culture of Cord Blood CD34+ Cells Induces Marked and Sustained Changes in Adhesion Receptor and CXCR4 Expressions

Stem cells (Dayton, Ohio), 2003-01, Vol.21 (1), p.61-70

2003

Volltextzugriff (PDF)

Identification of the CD33‐related Siglec receptor, Siglec‐5 (CD170), as a useful marker in both normal myelopoiesis and acute myeloid leukaemias

British journal of haematology, 2003-11, Vol.123 (3), p.420-430

2003

Volltextzugriff (PDF)

Cobblestone Area‐Forming Cells in Human Cord Blood Are Heterogeneous and Differ from Long‐Term Culture‐Initiating Cells

Stem cells (Dayton, Ohio), 2003-01, Vol.21 (6), p.694-701

2003

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

Ledipasvir and sofosbuvir plus ribavirin in patients with genotype 1 or 4 hepatitis C virus infection and advanced liver disease: a multicentre, open-label, randomised, phase 2 trial

Sofosbuvir and Ribavirin for Treatment of Compensated Recurrent Hepatitis C Virus Infection After Liver Transplantation

Sofosbuvir and Ribavirin Prevent Recurrence of HCV Infection After Liver Transplantation: An Open-Label Study

Pharmacokinetics, Pharmacodynamics, and Tolerability of GS-9851, a Nucleotide Analog Polymerase Inhibitor, following Multiple Ascending Doses in Patients with Chronic Hepatitis C Infection

Pharmacokinetics, Safety, and Tolerability of GS-9851, a Nucleotide Analog Polymerase Inhibitor for Hepatitis C Virus, following Single Ascending Doses in Healthy Subjects

A trial design to maximize knowledge of the effects of rodatristat ethyl in the treatment of pulmonary arterial hypertension (ELEVATE 2)

Ledipasvir and Sofosbuvir Plus Ribavirin for Treatment of HCV Infection in Patients With Advanced Liver Disease

Sofosbuvir compassionate use program for patients with severe recurrent hepatitis C after liver transplantation

Pair Programming in Middle School: What Does It Look Like?

Safety and efficacy of rodatristat ethyl for the treatment of pulmonary arterial hypertension (ELEVATE-2): a dose-ranging, randomised, multicentre, phase 2b trial

Analysis of hepatitis C viral kinetics during administration of two nucleotide analogues: sofosbuvir (GS―7977) and GS―0938

Hepatitis C Virus RNA Persists in Liver Explants of Most Patients Awaiting Liver Transplantation Treated With an Interferon-Free Regimen

365 Ledipasvir/Sofosbuvir With Ribavirin Is Safe and Efficacious in Decompensated and Post Liver Transplantation Patients With HCV Infection: Preliminary Results of the Prospective SOLAR 2 Trial

Tu1021 Ledipasvir/Sofosbuvir With Ribavirin for the Treatment of Fibrosing Cholestatic Hepatitis C After Liver Transplantation

226 Ledipasvir/Sofosbuvir With Ribavirin Is Safe in >600 Decompensated and Post Liver Transplantation Patients With HCV Infection: An Integrated Safety Analysis of the Solar 1 and Solar 2 Trials

On-treatment HCV RNA in patients with varying degrees of fibrosis and cirrhosis in the SOLAR-1 trial

SAFETY AND PHARMACOKINETICS OF GR270773, A NOVEL ANTISEPSIS COMPOUND, IN SEPTIC PATIENTS: 618

Adult bone marrow is a rich source of human mesenchymal ‘stem’ cells but umbilical cord and mobilized adult blood are not

Reducing Wet Ammonium Deposition in Rocky Mountain National Park: the Development and Evaluation of A Pilot Early Warning System for Agricultural Operations in Eastern Colorado

Variations in the Management of Closed Salter-Harris II Distal Tibia Fractures

Age and CRP Associated With Improved Tissue Pathogen Identification in Children With Blood Culture Negative Osteomyelitis: Results From the CORTICES Multicenter Database

Endothelial cell precursors are normal components of human umbilical cord blood

Cytokine Expansion Culture of Cord Blood CD34+ Cells Induces Marked and Sustained Changes in Adhesion Receptor and CXCR4 Expressions

Identification of the CD33‐related Siglec receptor, Siglec‐5 (CD170), as a useful marker in both normal myelopoiesis and acute myeloid leukaemias

Cobblestone Area‐Forming Cells in Human Cord Blood Are Heterogeneous and Differ from Long‐Term Culture‐Initiating Cells

Suchergebnisse filtern